Argenx to Buy Forte Biosciences for $2.2 Billion
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Argenx to Buy Forte Biosciences for $2.2 Billion" is generating significant coverage in the Business category, with 10 articles from 10 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Yahoo Finance, STAT, GlobeNewswire and Investing.com. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 93d ago.
Quick answers
Why is "Argenx to Buy Forte Biosciences for $2.2 Billion" trending?
Because 10 independent news sources published 10 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (10)
- argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline Yahoo Finance · 96d ago
- Argenx to buy autoimmune-focused Forte Biosciences for $2.2B STAT · 96d ago
- argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline GlobeNewswire · 96d ago
- TD Cowen downgrades Forte Biosciences stock rating on Argenx deal Investing.com · 96d ago
- Argenx to acquire Forte Biosciences for $2.2B Axios · 96d ago
- TD Cowen downgrades Forte Biosciences stock rating on Argenx deal By Investing.com Investing.com Canada · 96d ago
- argenx to buy Forte Bio for $2.2B in immunology push FirstWord Pharma · 96d ago
- Argenx to pick up autoimmune biotech Forte Biosciences for $2.2B Endpoints News · 96d ago
- Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug Fierce Biotech · 96d ago
- Argenx to Buy Forte Biosciences for $2.2 Billion WSJ · 96d ago
Topics
Related trends
Don’t Buy ‘Marathon’ As A ‘Donation’ For ‘Destiny’ Content, Says Bungie
Bungie tells players not to purchase Marathon as a donation to secure the future of Destiny 2.
Never Buy Ground Cinnamon Without Checking This, an Expert Warns
Wise Wife ground cinnamon is recalled across 14 states due to possible lead contamination.
The $6.3 Billion Binance Hack Was Pulled Off in Just 20 Minutes
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Big Tech’s $750 Billion AI Bet Collides With Slowing Core Growth
Big Tech's massive artificial intelligence investment boom collides directly with slowing core revenue growth.
Is Binance Being Hacked? $2 Billion Outflow Puts Customer Funds in Question
The world's largest cryptocurrency exchange investigates potential security breaches amid reports of significant fund outflows.
Josh Kushner’s Thrive to Buy ADT for $7.6 Billion
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.